Morphea after initiation of dupilumab in two pediatric atopic dermatitis patients

被引：2

作者：

Wang, Sonia ^{[1
,4
]}

Berry, Corbett T. ^{[2
]}

Treat, James R. ^{[2
,3
]}

Jen, Melinda ^{[2
,3
]}

机构：

[1] Univ Penn, Perelman Sch Med, Philadelphia, PA USA

[2] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA USA

[3] Childrens Hosp Philadelphia, Sect Pediat Dermatol, Philadelphia, PA USA

[4] Univ Penn, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA

来源：

PEDIATRIC DERMATOLOGY | 2023年 / 40卷 / 03期

关键词：

atopic dermatitis; drug-related side effects and adverse reactions; localized scleroderma; Th1-Th2; balance; LOCALIZED SCLERODERMA; PROFILES; CYTOKINE; BLOOD; CELLS;

D O I：

10.1111/pde.15200

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Morphea is a rare multifactorial autoimmune disorder characterized by a complex and dynamic interplay between Th1 and Th2 signaling. Active clinical trials are currently investigating the safety and efficacy of dupilumab for the treatment of primary morphea. Here, we present two cases of morphea that developed in pediatric atopic dermatitis patients treated with dupilumab. These findings may support a causal relationship between IL-4 receptor blockade and the development of the early inflammatory phase of morphea.

引用

页码：540 / 543

页数：4

共 50 条

[1] Psoriasiform Dermatitis After Initiation of Treatment with Dupilumab for Atopic Dermatitis
Fowler, Emilie
Silverberg, Jonathan I.
Fox, Joshua D.
Yosipovitch, Gil
DERMATITIS, 2019, 30 (03) : 234 - 236
[2] The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
Kamal, Mohamed A.
Kovalenko, Pavel
Kosloski, Matthew P.
Srinivasan, Kamal
Zhang, Yi
Rajadhyaksha, Manoj
Lai, Ching-Ha
Kanamaluru, Vanaja
Xu, Christine
Sun, Xian
Simpson, Eric L.
Paller, Amy S.
Siegfried, Elaine C.
Shumel, Brad
Bansal, Ashish
Al-Huniti, Nidal
Davis, John D.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1318 - 1328
[3] Exacerbation of psoriasis after initiation of dupilumab in atopic dermatitis patient
Dimitrov, Dimitre
Al Adawi, Meera
Abdelhadi, Zaidoon
Jafferany, Mohammad
DERMATOLOGIC THERAPY, 2020, 33 (04)
[4] Immunogenicity of dupilumab in adult and pediatric patients with atopic dermatitis
Kamal, Mohamed A.
Kosloski, Matthew P.
Lai, Ching-Ha
Partridge, Michael A.
Rajadhyaksha, Manoj
Kanamaluru, Vanaja
Bansal, Ashish
Shabbir, Arsalan
Shumel, Brad
Ardeleanu, Marius
Richards, Susan M.
Yan, Hong
Xu, Christine R.
Rodriguez-Marco, Ainara
Xiao, Jing
Khokhar, Faisal A.
Gherardi, Guy
Babilonia, Elisa
Maloney, Jennifer
Mortensen, Eric
Akinlade, Bolanle
Braunstein, Ned
Stahl, Neil
Torri, Albert
Davis, John D.
Dicioccio, A. Thomas
FRONTIERS IN IMMUNOLOGY, 2024, 15
[5] PEDIATRIC ATOPIC DERMATITIS PATIENTS' EXPERIENCES WITH DUPILUMAB INJECTIONS
Nguyen, Tan
Ragamin, Aviel
Lugtenberg, Marjolein
Pasmans, Suzanne
Schappin, Renske
ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 57 - 57
[6] Effectiveness of dupilumab in pediatric patients with a nummular phenotype of atopic dermatitis
Kim, Eun Jae
Hlobik, Madeline
Ho, Tina
PEDIATRIC DERMATOLOGY, 2024, 41 (03) : 455 - 457
[7] TWO CASES OF ALOPECIA AREATA AFTER TREATMENT WITH DUPILUMAB IN SEVERE ATOPIC DERMATITIS PATIENTS
Seo, Ji Min
Choi, Jin Young
Yu, Dong Soo
Lee, Young Bok
ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 29 - 29
[8] Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis
Fowler, Emilie
Rosen, Jordan
Lev-Tov, Hadar
Yosipovitch, Gil
ACTA DERMATO-VENEREOLOGICA, 2019, 99 (10) : 899 - 900
[9] Dupilumab therapy for alopecia areata in pediatric patients with concomitant atopic dermatitis
McKenzie, Paige L.
Castelo-Soccio, Leslie
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : 1691 - 1694
[10] Neutropenia on dupilumab in patients with atopic dermatitis
Pathmarajah, Piru
Corso, Roberto
Salam, Amr
Woolf, Richard
Smith, Catherine
Pink, Andrew
BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 83 - 83

← 1 2 3 4 5 →